Loading viewer...
earnings
Format: PDF earnings
Dr. Reddy's Laboratories reported Q3 FY23 financial results on January 25, 2023, achieving record quarterly revenues of Rs. 6,770 crore with 27% year-over-year growth. The company demonstrated strong profitability with PAT of Rs. 1,247 crore and free cash flow of Rs. 1,975 crore, while making progress in its biosimilars segment.
brochure
earnings
26 Pages
SSAB